JOHN A. CONNOLLY M.D. NPI 1174529309

NPI Details

John A. Connolly, M.D. is an urology in Burlingame, CA with 40 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. John A. Connolly, M.D. NPI is 1174529309. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1750 EL CAMINO REAL
SUITE #307
BURLINGAME, CA
ZIP 94010
Phone: (650) 259-1480
Fax: (650) 697-7361

The NPI 1174529309 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Automated urinalysis test (HCPCS:81003)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Complete ultrasound scan of pelvis (HCPCS:76856)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Initial dilation of urethra in female (HCPCS:53660)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Insertion of needle or tube into prostate for radiation therapy (HCPCS:55875)
• Ultrasonic guidance for administration of radiation therapy (HCPCS:76965)
• Injection procedure for imaging of bladder during voiding (HCPCS:51600)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Prostate resection (HCPCS:NAN14)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/22/2005 and was last updated on 6/23/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.